1. Home
  2. PTIX vs LFLY Comparison

PTIX vs LFLY Comparison

Compare PTIX & LFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • LFLY
  • Stock Information
  • Founded
  • PTIX 1994
  • LFLY 2010
  • Country
  • PTIX United States
  • LFLY United States
  • Employees
  • PTIX N/A
  • LFLY N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • LFLY Computer Software: Prepackaged Software
  • Sector
  • PTIX Health Care
  • LFLY Technology
  • Exchange
  • PTIX Nasdaq
  • LFLY Nasdaq
  • Market Cap
  • PTIX 3.9M
  • LFLY 4.0M
  • IPO Year
  • PTIX 2016
  • LFLY N/A
  • Fundamental
  • Price
  • PTIX $0.64
  • LFLY $1.54
  • Analyst Decision
  • PTIX
  • LFLY Strong Buy
  • Analyst Count
  • PTIX 0
  • LFLY 2
  • Target Price
  • PTIX N/A
  • LFLY $7.59
  • AVG Volume (30 Days)
  • PTIX 247.6K
  • LFLY 47.8K
  • Earning Date
  • PTIX 11-29-2024
  • LFLY 11-07-2024
  • Dividend Yield
  • PTIX N/A
  • LFLY N/A
  • EPS Growth
  • PTIX N/A
  • LFLY N/A
  • EPS
  • PTIX N/A
  • LFLY N/A
  • Revenue
  • PTIX N/A
  • LFLY $35,868,000.00
  • Revenue This Year
  • PTIX N/A
  • LFLY N/A
  • Revenue Next Year
  • PTIX N/A
  • LFLY N/A
  • P/E Ratio
  • PTIX N/A
  • LFLY N/A
  • Revenue Growth
  • PTIX N/A
  • LFLY N/A
  • 52 Week Low
  • PTIX $0.49
  • LFLY $1.32
  • 52 Week High
  • PTIX $1.87
  • LFLY $6.49
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 49.61
  • LFLY 39.51
  • Support Level
  • PTIX $0.52
  • LFLY $1.32
  • Resistance Level
  • PTIX $1.09
  • LFLY $1.87
  • Average True Range (ATR)
  • PTIX 0.15
  • LFLY 0.19
  • MACD
  • PTIX 0.01
  • LFLY -0.01
  • Stochastic Oscillator
  • PTIX 20.91
  • LFLY 32.74

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About LFLY Leafly Holdings Inc.

Leafly Holdings Inc operates an online cannabis information resource platform. It offers cannabis retailers and brands subscription-based marketplace listings that provide its cannabis audience with information, reviews, menus, and ordering and delivery options through legal retailers.

Share on Social Networks: